Cycle-length evidence
Semax cycle length: what human studies ran
Approved outside the USBLimited human data
Short answer: there is no established Semax cycle length, and we found no human studies that report one.
Treatment and follow-up in human studies
No human study durations are recorded.
What has not been tested
- On-and-off schedules or breaks between courses.
- Repeated courses and long-term exposure beyond the periods listed.
- Semax combined with other compounds, unless a study above says so.
Frequently asked questions
Is there an established Semax cycle length?
No. We found no human studies that report a treatment duration for Semax.
What is the longest human study of Semax?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
References
- Semax, an analogue of adrenocorticotropin (4-10), binds specifically and increases levels of brain-derived neurotrophic factor protein in rat basal forebrain J Neurochem. 2006
- Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents Neurochem Res. 2005
- The efficacy of semax in the treatment of patients at different stages of ischemic stroke (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 2018
- Effectiveness of semax in acute period of hemispheric ischemic stroke: a clinical and electrophysiological study (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 1997
- Semax in prevention of disease progress and development of exacerbations in patients with cerebrovascular insufficiency (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 2005
- ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental Stroke Biomedicines. 2024
- Development of Peptide Biopharmaceuticals in Russia Pharmaceutics. 2022
- Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion Int J Mol Sci. 2021
- DailyMed drug-label search for semax (conducted for this entry) FDA DailyMed. 2026
- WADA International Standard: Prohibited List 2026 (S0 and S2.2) WADA Prohibited List. 2026
- PubChem CID 9811102 (Semax) PubChem. 2026
- Genes That Associated with Action of ACTH-like Peptides with Neuroprotective Potential in Rat Brain Regions with Different Degrees of Ischemic Damage Int J Mol Sci. 2025
- ClinicalTrials.gov intervention search for semax (conducted for this entry) ClinicalTrials.gov. 2026